United States Biotechnology & Medical Research

Aerie Pharmaceuticals Inc (AERI)

Track

Track

Ticker: AERI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Aerie Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
100.14
Quantity 54,256 +4.6%
Value US$3,976,088
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
64.79
Quantity 50,959 +20.4%
Value US$1,027,645
Cagle Gerald D. Non-Executive Director
Transaction date
Sale
Price
64.12
Quantity 52,784 +10.7%
Value US$2,230,646
RUBINO RICHARD J Chief Financial Officer
Transaction date
Purchase
Price
19.93
Quantity 5,040 +1.5%
Value US$100,447
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Purchase
Price
19.95
Quantity 2,000 +1.0%
Value US$39,900
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Purchase
Price
18.93
Quantity 24,250 +14.1%
Value US$459,052
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
23.42
Quantity 38,300 +1.7%
Value US$896,986
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
23.68
Quantity 6,700 +0.3%
Value US$158,656
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
23.25
Quantity 1,153 +0.1%
Value US$26,807
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
23.21
Quantity 50,000 +2.3%
Value US$1,160,500
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
23.34
Quantity 3,847 +0.2%
Value US$89,789
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
24.23
Quantity 100,000 +4.9%
Value US$2,423,000
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
23.73
Quantity 100,000 +5.1%
Value US$2,373,000
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
25.52
Quantity 178,903 +15.8%
Value US$4,565,605
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
24.92
Quantity 71,097 +6.7%
Value US$1,771,737
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
24.43
Quantity 189,555 +21.8%
Value US$4,630,829
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
47.02
Quantity 1,500 -1.5%
Value US$70,530
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
46.03
Quantity 9,500 -8.9%
Value US$437,314
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
35.21
Quantity 11,000 -9.3%
Value US$387,313
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
40.55
Quantity 299 -0.3%
Value US$12,123
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
39.79
Quantity 10,701 -8.3%
Value US$425,770
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
41.75
Quantity 2,000 +11.2%
Value US$83,493
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
54.22
Quantity 7,792 -5.7%
Value US$422,517
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
52.99
Quantity 3,208 -2.3%
Value US$170,003
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
61.34
Quantity 1,670 -1.2%
Value US$102,435
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
60.43
Quantity 9,330 -6.3%
Value US$563,769
RUBINO RICHARD J Chief Financial Officer Officer
Transaction date
Planned sale
Price
61.01
Quantity 108 -0.0%
Value US$6,589
RUBINO RICHARD J Chief Financial Officer Officer
Transaction date
Planned sale
Price
60.36
Quantity 16,497 -4.9%
Value US$995,797
RUBINO RICHARD J Chief Financial Officer Officer
Transaction date
Planned sale
Price
61.01
Quantity 500 -0.1%
Value US$30,505
RUBINO RICHARD J Chief Financial Officer Officer
Transaction date
Planned sale
Price
60.18
Quantity 49,500 -12.9%
Value US$2,978,940
RUBINO RICHARD J Chief Financial Officer Officer
Transaction date
Planned sale
Price
60.00
Quantity 2 -0.0%
Value US$120
RUBINO RICHARD J Chief Financial Officer Officer
Transaction date
Sale
Price
60.17
Quantity 34,512 -8.3%
Value US$2,076,608
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
61.00
Quantity 1,000 -0.7%
Value US$61,000
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
60.00
Quantity 10,000 -6.3%
Value US$600,024
MITRO THOMAS A President and COO Officer
Transaction date
Planned sale
Price
61.01
Quantity 451 -0.9%
Value US$27,513
MITRO THOMAS A President and COO Officer
Transaction date
Planned sale
Price
60.27
Quantity 189,549 -78.5%
Value US$11,423,493
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
68.69
Quantity 4,790 -2.9%
Value US$329,003
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
68.00
Quantity 6,210 -3.7%
Value US$422,295
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
67.09
Quantity 2,600 -1.5%
Value US$174,440
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
66.15
Quantity 8,400 -4.7%
Value US$555,624
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
62.92
Quantity 4,996 -3.8%
Value US$314,350
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
61.90
Quantity 45,004 -25.5%
Value US$2,785,946
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
64.52
Quantity 29,717 -19.0%
Value US$1,917,362
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
63.35
Quantity 20,283 -11.5%
Value US$1,284,924
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
62.80
Quantity 16,386 -11.5%
Value US$1,029,092
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
62.06
Quantity 33,614 -19.1%
Value US$2,085,957
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
59.21
Quantity 3,000 -1.6%
Value US$177,641
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
58.57
Quantity 8,000 -4.2%
Value US$468,595
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
61.10
Quantity 4,338 -3.3%
Value US$265,044
ANIDO VICENTE JR Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
60.44
Quantity 45,662 -25.9%
Value US$2,760,003
Kopczynski Casey C. Chief Scientific Officer Officer
Transaction date
Sale
Price
50.15
Quantity 2,708 -1.4%
Value US$135,806
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
49.45
Quantity 1,000 +6.6%
Value US$49,450
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
50.25
Quantity 1,000 +7.1%
Value US$50,245
Foresite Capital Management II, LLC Large shareholder
Transaction date
Sale
Price
55.95
Quantity 10,182 -0.5%
Value US$569,683
Foresite Capital Management II, LLC Large shareholder
Transaction date
Sale
Price
55.95
Quantity 9,818 -0.6%
Value US$549,317
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
39.90
Quantity 1,000 +8.4%
Value US$39,900
Cagle Gerald D.
Transaction date
Purchase
Price
41.80
Quantity 1,000 +9.2%
Value US$41,800
Cagle Gerald D.
Transaction date
Purchase
Price
41.60
Quantity 1,000 +10.1%
Value US$41,600
DUYK GEOFFREY M Non-Executive Director
Transaction date
Sale
Price
46.81
Quantity 20,796 -85.9%
Value US$973,438
DUYK GEOFFREY M Non-Executive Director
Transaction date
Sale
Price
46.46
Quantity 20,795 -46.2%
Value US$966,059
Foresite Capital Management II, LLC Large shareholder
Transaction date
Sale
Price
40.34
Quantity 25,187 -1.5%
Value US$1,016,041
Foresite Capital Management II, LLC Large shareholder
Transaction date
Sale
Price
40.34
Quantity 24,813 -1.5%
Value US$1,000,954
Foresite Capital Management II, LLC Large shareholder
Transaction date
Purchase
Price
17.50
Quantity 250,000 +17.3%
Value US$4,375,000
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
16.60
Quantity 476 +6.2%
Value US$7,902
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
16.60
Quantity 1,524 +24.6%
Value US$25,298
Cagle Gerald D. Non-Executive Director
Transaction date
Purchase
Price
15.46
Quantity 500 +8.8%
Value US$7,729
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-11-12 2020-11-11 PlS Planned sale
Kopczynski Casey C.

Chief Scientific Officer

Officer
54,256 +4.6%
100.14
US$3,976,088 		54,256 +4.6% 100.14 US$3,976,088
2020-11-12 2020-11-10 PlS Planned sale
Kopczynski Casey C.

Chief Scientific Officer

Officer
50,959 +20.4%
64.79
US$1,027,645 		50,959 +20.4% 64.79 US$1,027,645
2020-05-12 2020-05-08 S Sale
Cagle Gerald D.
Non-Executive Director
52,784 +10.7%
64.12
US$2,230,646 		52,784 +10.7% 64.12 US$2,230,646
2020-03-02 2020-02-27 S Sale
Foresite Capital Management II, LLC
Large shareholder
271,767 -18.1%
17.07
US$4,639,063 		271,767 -18.1% 17.07 US$4,639,063
2020-03-02 2020-02-27 S Sale
Foresite Capital Management II, LLC
Large shareholder
425,457 -18.1%
17.07
US$7,262,551 		425,457 -18.1% 17.07 US$7,262,551
2020-03-02 2020-02-27 S Sale
Foresite Capital Management II, LLC
Large shareholder
302,776 -18.1%
17.07
US$5,168,386 		302,776 -18.1% 17.07 US$5,168,386
2019-09-09 2019-09-09 B Purchase
RUBINO RICHARD J

Chief Financial Officer
5,040 +1.5%
19.93
US$100,447 		5,040 +1.5% 19.93 US$100,447
2019-09-09 2019-09-09 B Purchase
ANIDO VICENTE JR

Chief Executive Officer

Executive Director
2,000 +1.0%
19.95
US$39,900 		2,000 +1.0% 19.95 US$39,900
2019-09-09 2019-09-09 B Purchase
ANIDO VICENTE JR

Chief Executive Officer

Executive Director
24,250 +14.1%
18.93
US$459,052 		24,250 +14.1% 18.93 US$459,052
2019-09-06 2019-09-05 B Purchase
Foresite Capital Management II, LLC
Large shareholder
15,700 +0.7%
18.42
US$289,194 		15,700 +0.7% 18.42 US$289,194
2019-09-06 2019-09-04 B Purchase
Foresite Capital Management II, LLC
Large shareholder
90,900 +6.9%
18.48
US$1,679,832 		90,900 +6.9% 18.48 US$1,679,832
2019-09-06 2019-09-04 B Purchase
Foresite Capital Management II, LLC
Large shareholder
9,300 +0.4%
18.48
US$171,864 		9,300 +0.4% 18.48 US$171,864
2019-09-04 2019-09-03 B Purchase
Foresite Capital Management II, LLC
Large shareholder
15,100 +0.7%
21.45
US$323,895 		15,100 +0.7% 21.45 US$323,895
2019-09-04 2019-09-03 B Purchase
Foresite Capital Management II, LLC
Large shareholder
34,900 +1.5%
20.54
US$716,846 		34,900 +1.5% 20.54 US$716,846
2019-09-04 2019-08-30 B Purchase
Foresite Capital Management II, LLC
Large shareholder
25,000 +1.1%
21.36
US$534,000 		25,000 +1.1% 21.36 US$534,000
2019-08-23 2019-08-23 B Purchase Foresite Capital Management II, LLC Large shareholder
38,300 +1.7%
23.42
US$896,986 		38,300 +1.7% 23.42 US$896,986
2019-08-23 2019-08-22 B Purchase Foresite Capital Management II, LLC Large shareholder
6,700 +0.3%
23.68
US$158,656 		6,700 +0.3% 23.68 US$158,656
2019-08-23 2019-08-21 B Purchase Foresite Capital Management II, LLC Large shareholder
1,153 +0.1%
23.25
US$26,807 		1,153 +0.1% 23.25 US$26,807
2019-08-20 2019-08-20 B Purchase Foresite Capital Management II, LLC Large shareholder
50,000 +2.3%
23.21
US$1,160,500 		50,000 +2.3% 23.21 US$1,160,500
2019-08-20 2019-08-19 B Purchase Foresite Capital Management II, LLC Large shareholder
3,847 +0.2%
23.34
US$89,789 		3,847 +0.2% 23.34 US$89,789
2019-08-20 2019-08-16 B Purchase Foresite Capital Management II, LLC Large shareholder
100,000 +4.9%
24.23
US$2,423,000 		100,000 +4.9% 24.23 US$2,423,000
2019-08-14 2019-08-14 B Purchase Foresite Capital Management II, LLC Large shareholder
100,000 +5.1%
23.73
US$2,373,000 		100,000 +5.1% 23.73 US$2,373,000
2019-08-14 2019-08-13 B Purchase Foresite Capital Management II, LLC Large shareholder
178,903 +15.8%
25.52
US$4,565,605 		178,903 +15.8% 25.52 US$4,565,605
2019-08-14 2019-08-13 B Purchase Foresite Capital Management II, LLC Large shareholder
71,097 +6.7%
24.92
US$1,771,737 		71,097 +6.7% 24.92 US$1,771,737
2019-08-14 2019-08-12 B Purchase Foresite Capital Management II, LLC Large shareholder
189,555 +21.8%
24.43
US$4,630,829 		189,555 +21.8% 24.43 US$4,630,829
2019-02-01 2019-02-01 PlS Planned sale
Kopczynski Casey C.

Chief Scientific Officer

Officer
1,500 -1.5%
47.02
US$70,530 		1,500 -1.5% 47.02 US$70,530
2019-02-01 2019-02-01 PlS Planned sale
Kopczynski Casey C.

Chief Scientific Officer

Officer
9,500 -8.9%
46.03
US$437,314 		9,500 -8.9% 46.03 US$437,314
2019-01-02 2019-01-02 PlS Planned sale
Kopczynski Casey C.

Chief Scientific Officer

Officer
11,000 -9.3%
35.21
US$387,313 		11,000 -9.3% 35.21 US$387,313
2018-12-04 2018-12-03 PlS Planned sale Kopczynski Casey C.

Chief Scientific Officer

Officer
299 -0.3%
40.55
US$12,123 		299 -0.3% 40.55 US$12,123
2018-12-04 2018-12-03 PlS Planned sale Kopczynski Casey C.

Chief Scientific Officer

Officer
10,701 -8.3%
39.79
US$425,770 		10,701 -8.3% 39.79 US$425,770
2018-11-19 2018-11-16 B Purchase Cagle Gerald D. Non-Executive Director
2,000 +11.2%
41.75
US$83,493 		2,000 +11.2% 41.75 US$83,493
2018-11-02 2018-11-01 PlS Planned sale Kopczynski Casey C.

Chief Scientific Officer

Officer
7,792 -5.7%
54.22
US$422,517 		7,792 -5.7% 54.22 US$422,517
2018-11-02 2018-11-01 PlS Planned sale Kopczynski Casey C.

Chief Scientific Officer

Officer
3,208 -2.3%
52.99
US$170,003 		3,208 -2.3% 52.99 US$170,003
2018-10-01 2018-10-01 PlS Planned sale Kopczynski Casey C.

Chief Scientific Officer

Officer
1,670 -1.2%
61.34
US$102,435 		1,670 -1.2% 61.34 US$102,435
2018-10-01 2018-10-01 PlS Planned sale Kopczynski Casey C.

Chief Scientific Officer

Officer
9,330 -6.3%
60.43
US$563,769 		9,330 -6.3% 60.43 US$563,769
2018-09-28 2018-09-27 PlS Planned sale RUBINO RICHARD J

Chief Financial Officer

Officer
108 -0.0%
61.01
US$6,589 		108 -0.0% 61.01 US$6,589
2018-09-28 2018-09-27 PlS Planned sale RUBINO RICHARD J

Chief Financial Officer

Officer
16,497 -4.9%
60.36
US$995,797 		16,497 -4.9% 60.36 US$995,797
2018-09-28 2018-09-26 PlS Planned sale RUBINO RICHARD J

Chief Financial Officer

Officer
500 -0.1%
61.01
US$30,505 		500 -0.1% 61.01 US$30,505
2018-09-28 2018-09-26 PlS Planned sale RUBINO RICHARD J

Chief Financial Officer

Officer
49,500 -12.9%
60.18
US$2,978,940 		49,500 -12.9% 60.18 US$2,978,940
2018-09-18 2018-09-14 PlS Planned sale RUBINO RICHARD J

Chief Financial Officer

Officer
2 -0.0%
60.00
US$120 		2 -0.0% 60.00 US$120
2018-09-14 2018-09-13 S Sale RUBINO RICHARD J

Chief Financial Officer

Officer
34,512 -8.3%
60.17
US$2,076,608 		34,512 -8.3% 60.17 US$2,076,608
2018-09-06 2018-09-04 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
1,000 -0.7%
61.00
US$61,000 		1,000 -0.7% 61.00 US$61,000
2018-09-06 2018-09-04 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
10,000 -6.3%
60.00
US$600,024 		10,000 -6.3% 60.00 US$600,024
2018-08-29 2018-08-27 PlS Planned sale MITRO THOMAS A

President and COO

Officer
451 -0.9%
61.01
US$27,513 		451 -0.9% 61.01 US$27,513
2018-08-29 2018-08-27 PlS Planned sale MITRO THOMAS A

President and COO

Officer
189,549 -78.5%
60.27
US$11,423,493 		189,549 -78.5% 60.27 US$11,423,493
2018-08-02 2018-08-01 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
4,790 -2.9%
68.69
US$329,003 		4,790 -2.9% 68.69 US$329,003
2018-08-02 2018-08-01 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
6,210 -3.7%
68.00
US$422,295 		6,210 -3.7% 68.00 US$422,295
2018-07-05 2018-07-02 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
2,600 -1.5%
67.09
US$174,440 		2,600 -1.5% 67.09 US$174,440
2018-07-05 2018-07-02 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
8,400 -4.7%
66.15
US$555,624 		8,400 -4.7% 66.15 US$555,624
2018-06-13 2018-06-11 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
4,996 -3.8%
62.92
US$314,350 		4,996 -3.8% 62.92 US$314,350
2018-06-13 2018-06-11 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
45,004 -25.5%
61.90
US$2,785,946 		45,004 -25.5% 61.90 US$2,785,946
2018-06-08 2018-06-08 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
29,717 -19.0%
64.52
US$1,917,362 		29,717 -19.0% 64.52 US$1,917,362
2018-06-08 2018-06-08 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
20,283 -11.5%
63.35
US$1,284,924 		20,283 -11.5% 63.35 US$1,284,924
2018-06-08 2018-06-07 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
16,386 -11.5%
62.80
US$1,029,092 		16,386 -11.5% 62.80 US$1,029,092
2018-06-08 2018-06-07 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
33,614 -19.1%
62.06
US$2,085,957 		33,614 -19.1% 62.06 US$2,085,957
2018-06-08 2018-06-06 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
3,000 -1.6%
59.21
US$177,641 		3,000 -1.6% 59.21 US$177,641
2018-06-08 2018-06-06 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
8,000 -4.2%
58.57
US$468,595 		8,000 -4.2% 58.57 US$468,595
2018-06-08 2018-06-06 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
4,338 -3.3%
61.10
US$265,044 		4,338 -3.3% 61.10 US$265,044
2018-06-08 2018-06-06 PlS Planned sale ANIDO VICENTE JR

Chief Executive Officer

Executive Director
45,662 -25.9%
60.44
US$2,760,003 		45,662 -25.9% 60.44 US$2,760,003
2018-05-29 2018-05-29 S Sale Kopczynski Casey C.

Chief Scientific Officer

Officer
2,708 -1.4%
50.15
US$135,806 		2,708 -1.4% 50.15 US$135,806
2018-05-25 2018-05-25 B Purchase Cagle Gerald D. Non-Executive Director
1,000 +6.6%
49.45
US$49,450 		1,000 +6.6% 49.45 US$49,450
2018-05-22 2018-05-21 B Purchase Cagle Gerald D. Non-Executive Director
1,000 +7.1%
50.25
US$50,245 		1,000 +7.1% 50.25 US$50,245
2017-05-31 2017-05-26 S Sale Foresite Capital Management II, LLC Large shareholder
10,182 -0.5%
55.95
US$569,683 		10,182 -0.5% 55.95 US$569,683
2017-05-31 2017-05-26 S Sale Foresite Capital Management II, LLC Large shareholder
9,818 -0.6%
55.95
US$549,317 		9,818 -0.6% 55.95 US$549,317
2017-05-17 2017-05-09 B Purchase Cagle Gerald D. Non-Executive Director
1,000 +8.4%
39.90
US$39,900 		1,000 +8.4% 39.90 US$39,900
2017-04-20 2017-04-19 B Purchase Cagle Gerald D.
1,000 +9.2%
41.80
US$41,800 		1,000 +9.2% 41.80 US$41,800
2017-04-20 2017-04-19 B Purchase Cagle Gerald D.
1,000 +10.1%
41.60
US$41,600 		1,000 +10.1% 41.60 US$41,600
2017-02-16 2017-02-15 S Sale DUYK GEOFFREY M Non-Executive Director
20,796 -85.9%
46.81
US$973,438 		20,796 -85.9% 46.81 US$973,438
2017-02-16 2017-02-14 S Sale DUYK GEOFFREY M Non-Executive Director
20,795 -46.2%
46.46
US$966,059 		20,795 -46.2% 46.46 US$966,059
2016-10-07 2016-10-06 S Sale Foresite Capital Management II, LLC Large shareholder
25,187 -1.5%
40.34
US$1,016,041 		25,187 -1.5% 40.34 US$1,016,041
2016-10-07 2016-10-06 S Sale Foresite Capital Management II, LLC Large shareholder
24,813 -1.5%
40.34
US$1,000,954 		24,813 -1.5% 40.34 US$1,000,954
2016-07-26 2016-07-22 B Purchase Foresite Capital Management II, LLC Large shareholder
250,000 +17.3%
17.50
US$4,375,000 		250,000 +17.3% 17.50 US$4,375,000
2016-04-26 2015-08-28 B Purchase Cagle Gerald D. Non-Executive Director
476 +6.2%
16.60
US$7,902 		476 +6.2% 16.60 US$7,902
2016-04-26 2015-08-28 B Purchase Cagle Gerald D. Non-Executive Director
1,524 +24.6%
16.60
US$25,298 		1,524 +24.6% 16.60 US$25,298
2016-04-26 2015-08-12 B Purchase Cagle Gerald D. Non-Executive Director
500 +8.8%
15.46
US$7,729 		500 +8.8% 15.46 US$7,729
Explore more

More insider trading research around Aerie Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America